This course has expired. View available courses.
Pediatrics
Evaluating pediatric influenza vaccines in 2022–2023 — Providing optimal protection for the pediatric population — for Physicians
Influenza vaccination remains a critical public health tool to reduce outbreaks of endemic influenza infection. This program summarizes the key National Advisory Committee on Immunization (NACI) influenza vaccine recommendations and the differences between currently marketed vaccines in Canada. The overall goal of this program is to increase clinicians' confidence in applying the NACI recommendations for pediatric influenza immunization for the 2022–2023 influenza season.
DURATION
1 hr
PROFESSION
Physician
# OF CREDITS
0
ACCREDITATION
Unaccredited
EXPIRY DATE
2023-12-31
Influenza vaccination remains a critical public health tool to reduce outbreaks of endemic influenza infection. This program summarizes the key National Advisory Committee on Immunization (NACI) influenza vaccine recommendations and the differences between currently marketed vaccines in Canada. The overall goal of this program is to increase clinicians’ confidence in applying the NACI recommendations for pediatric influenza immunization for the 2022–2023 influenza season.
This program is made possible through educational support from CSL Seqirus.
Faculty
Dr. Mark Loeb, MD, M.Sc, FRCPC
Dr. Anas Nseir, MD, FCFP, B.Pharm
Dr. Chandi Chandrasena, MD, CCFP, FCFP
Dr. Vivien Brown, MDCM, CCFP, FCFP, NCMP
Sherilyn Houle, MSP, PhD, CTH, AFTM RCPS (Glasg)
Carlene Oleksyn, B.S.P., R.Ph, CTH, CDE
Learning objectives
- Review the pediatric burden of disease in the coming 2022–2023 influenza season — notably, the severe underrepresentation in the pediatric population, including those at high risk of influenza infection and complications.
- Identify the influenza immunization options available to the pediatric population, including a review of relevant studies pertaining to different vaccines.
- Recognize the potential for egg adaptation in the influenza vaccine manufacturing process.
- Explore the level of egg adaptation in recent years and its impact on vaccine effectiveness.
- Examine new technologies that prevent egg adaptation (e.g., mammalian cell production).
Accreditation
#
of credits: 0
Duration: 1 hr
FAQs & HELP
MDBriefCase Group specializes in accredited, online continuing professional development (CPD) programs, custom tailored for specific international markets and available on a convenient online platform.
All content is developed by leading specialists and peer-reviewed by experts at respected institutions, which keeps more than 280,000 global healthcare professionals at the forefront of the latest evidence and protocols worldwide.
The vast majority of our programs are accredited by one or more respected institutions. We do provide unaccredited content to ensure that healthcare professionals have access to relevant practical resources in addition to accredited learning.
Specific accrediting information (including the accrediting body, along with the type and number of credits) can be found on the “Main” page and/or “Accreditation” page of each program. In order to qualify for accreditation and obtain your certificate, you must successfully complete the requirements listed on the “Accreditation” or “CME Information” pages available in each program.
MDBriefCase Group works with various institutions to provide peer-reviewed, up-to-date accredited content. Our programs and resources are provided via collaboration between medical writers, faculty members, associations, universities and other relevant organizations. The content you were recommended is likely valued by your society or association and is conveniently provided to you free of charge on an MDBriefCase Group platform.
Specific accrediting information (including the accrediting body, along with the type and number of credits) can be found on the “Main” page and/or “Accreditation” page of each program. In order to qualify for accreditation and obtain your certificate, you must successfully complete the requirements listed on the “Accreditation” or “CME Information” pages available in each program.
If you are interested in learning more about supporting one of our programs, please contact us.
If you are interested in working with MDBriefCase Group as a writer or committee member, please contact us.
To access the MDBriefCase Group privacy policy, please click here.
No, registration with MDBriefCase is free!
To access your profile, visit My Profile. If you would like to update the information here don’t forget to hit the ‘save’ button when you are finished. Your profile is where you can control what email communications you receive.
If you have forgotten your password, you can reset your password. To access this page from the Login page, click Forgot password. Enter the email address you registered with and you will receive an email with a link to reset your password.
Please note: if you submitted multiple password resets, only the link on the most recent email is valid.
You can unsubscribe from MDBriefCase Group emails by clicking the unsubscribe button located at the bottom of each of our emails.
1 hr
Duration
Physician
Profession
0
# of credits
Learning Objectives
- Review the pediatric burden of disease in the coming 2022–2023 influenza season — notably, the severe underrepresentation in the pediatric population, including those at high risk of influenza infection and complications.
- Identify the influenza immunization options available to the pediatric population, including a review of relevant studies pertaining to different vaccines.
- Recognize the potential for egg adaptation in the influenza vaccine manufacturing process.
- Explore the level of egg adaptation in recent years and its impact on vaccine effectiveness.
- Examine new technologies that prevent egg adaptation (e.g., mammalian cell production).
Unaccredited
ACCREDITATION
Pediatrics
Learning Category
General
Topic
0
Price
2023-12-31
Expiry Date
CAN-eng
Region/Language
Course Description
Influenza vaccination remains a critical public health tool to reduce outbreaks of endemic influenza infection. This program summarizes the key National Advisory Committee on Immunization (NACI) influenza vaccine recommendations and the differences between currently marketed vaccines in Canada. The overall goal of this program is to increase clinicians’ confidence in applying the NACI recommendations for pediatric influenza immunization for the 2022–2023 influenza season.
This program is made possible through educational support from CSL Seqirus.
Faculty
Dr. Mark Loeb, MD, M.Sc, FRCPC
Dr. Anas Nseir, MD, FCFP, B.Pharm
Dr. Chandi Chandrasena, MD, CCFP, FCFP
Dr. Vivien Brown, MDCM, CCFP, FCFP, NCMP
Sherilyn Houle, MSP, PhD, CTH, AFTM RCPS (Glasg)
Carlene Oleksyn, B.S.P., R.Ph, CTH, CDE
Accreditation
<!–
This Self-Learning program has been certified by the College of Family Physicians of Canada for up to 1.0 Mainpro+ Credit(s).
Cert+ Program ID#: 197744
–>
1 hr
Duration
0
Price
0
# of credits
